Cancer Research Program logo

Emerging Diagnostic and Treatment Opportunities for Neuroedocrine Tumors of the Gastrointestinal Tract

Recent advancements in diagnostic imaging and chemotherapeutics are reshaping management of neuroendocrine tumors (NETs). During Emerging Diagnostic and Treatment Opportunities for Neuroendocrine Tumors of the Gastrointestinal Tract, the panel presents the updated diagnosis and management of both primary and metastatic NETs in the context of these innovations and their impact on outcomes.

Target Audience

  • Breast surgeons
  • Cancer registrars 
  • Colorectal surgeons
  • General surgeons
  • Nurses
  • Nurse practitioners
  • Other advanced practice professionals
  • Physician assistants
  • Physicians in accredited cancer centers and programs
  • Surgical oncologists
     

Learning Objectives

  • Outline the context of these innovations for both primary and metastatic NETs.
  • Discuss the impact of the changes to diagnosis and treatment on patient outcomes.
  • Understand the indications and rationale for new imaging modalities and chemotherapy options for patients with gastrointestinal NETs.
     

Contact

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 CE Contact hours
  • 1.00 Certificate of Completion
Course opens: 
04/01/2021
Course expires: 
04/02/2024

Disclosure Information

In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all financial relationships with any commercial interest (termed by the ACCME as “ineligible companies”, defined below) held in the last 24 months (see below for definitions). Please note that first authors were required to collect and submit disclosure information on behalf all other authors/contributors, if applicable.

Ineligible company

The ACCME defines an “ineligible company” as any entity producing, marketing, re-selling, or distributing health care goods or services used on or consumed by patients. Providers of clinical services directly to patients are NOT included in this definition.

Financial Relationships

Relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit.  Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected.  ACCME considers relationships of the person involved in the CME activity to include financial relationships of a spouse or partner.

Conflict of Interest

Circumstances create a conflict of interest when an individual has an opportunity to affect CME content about products or services of an ineligible company with which he/she has a financial relationship.

The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the educational activity.  Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during the educational activity, please report it on the evaluation. 

Speakers/Moderators/Discussants/Authors Disclosures

Clancy Clark, MD, FACS (moderator) – Nothing to disclose
Wake Forest Baptist Health

Flavio Rocha, MD, FACS, FSSO (moderator) – Nothing to disclose
Oregon Health & Science University/Knight Cancer Institute

Delphine Chen, MD (speaker) – Nothing to disclose
University of Washington/Seattle Cancer Care Alliance

Caio Max Sao Pedro Rocha Lima, MD, MS (speaker) – Nothing to disclose
Wake Forest University/Baptist Medical Center

Jonathon McConathy, MD, PhD (speaker) – honorarium and research support for consulting at Eli Lilly/Avid, honorarium for consulting at GE Healthcare, honorarium and research support for consulting at Blue Earth Diagnostics, research support for clinical trial at Cytosite Biopharma, honorarium for consulting at ImaginAb, honorarium for consulting at Canon Medical

J. Bart Rose, MD, MAS, FACS (speaker) – Nothing to disclose
University of Alabama, Birmingham

Planning Committee Disclosures

Judy Boughey, MD, FACS – Research funding support for clinical trial from Eli Lilly
Mayo Clinic
 
Christina Roland, MD, FACS – Research funds to institution from Bristol Myers Squibb
MD Anderson Cancer Center 
 
Asa Carter, MBA, CTR—Nothing to disclose    
American College of Surgeons 
            
Amanda Francescatti, MS – Nothing to disclose 
American College of Surgeons 
 
Linda Zheng – Nothing to disclose 
American College of Surgeons 

Continuing Medical Education Credit Information

Accreditation

The American College of Surgeons is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA PRA Category 1 Credits™

The American College of Surgeons designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American College of Surgeons and ACGME Logos

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 CE Contact hours
  • 1.00 Certificate of Completion
Please login or register to take this course.